COVID-19 led to the cancellation of an international gastroenterology congress, during which our client had planned an educational
symposium to highlight the latest advancements in Inflammatory Bowel Disease (IBD).
Today is Rare Disease Day, so we wanted to take this opportunity to raise awareness of hereditary angioedema (HAE) – a rare disease that we have a lot of expertise in, here at BEYOND Communication.
In our second blog post on the topic of hereditary angioedema (HAE), we wanted to highlight a review article by Xu et al., (link to open-access article), which explored the possibility of an interaction between HAE and coronavirus disease 2019 (COVID-19), based on the pathophysiologic mechanisms underlying these two clinical conditions.
As we are heading for a new year, we look back at stressful and challenging months, with a pandemic as one of the great disasters to befall our planet. 2020 has been a difficult year for many companies, but also a year of adaptation and transformation.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic – has led to considerable morbidity and mortality worldwide.